Sjögren's Syndrome

References

Citations

1. Jonsson R, et al. (2005). Sjögren's syndrome. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions: A Textbook of Rheumatology, 15th ed., vol. 2, pp. 1681–1705. Philadelphia: Lippincott Williams and Wilkins.

2. Fox RI (2000). Sjögren's syndrome: Current therapies remain inadequate for a common disease. Expert Opinion on Investigational Drugs, 9(9): 2007–2016.

3. Fox RI, et al. (2000). Update in Sjögren syndrome. Current Opinion in Rheumatology, 12(5): 391–398.

4. Petrone D, et al. (2002). A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis and Rheumatism, 46(3): 748–754.

5. Fife RS, et al. (2002). Cevimeline for the treatment of xerostomia in patients with Sjögren's syndrome. Archives of Internal Medicine, 162: 1293–1300.

6. Carsons S (2005). Sjögren's syndrome. In ED Harris Jr et al., eds., Kelley's Textbook of Rheumatology, 7th ed., vol. 2, chap. 69, pp. 1105–1124. Philadelphia: Elsevier Saunders.

7. Ophthalmic cyclosporine (Restatis) for dry eye disease (2003). Medical Letter on Drugs and Therapeutics, 45(W1157B): 42–43.

8. Steinfeld SD, et al. (2002). Infliximab in primary Sjögren's syndrome. Arthritis and Rheumatism, 46(12): 3301–3303.

Go to previous section	Go to top of page	Go to next section
Author:	Jan Nissl, RN, BS	Last Updated: May 18, 2006
Medical Review:	Adam Husney, MD - Family Medicine Stanford M. Shoor, MD - Rheumatology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.